Palvella Therapeutics, Inc. PVLA
162.28 USD +9.35 (+6.11%)
At closeNov 4, 2026, 4:26 PM EST
162.28 0.00 0.00%
After hours · Nov 4, 4:26 PM ET
147.47 Day range 163.75
72.23 52-week range 163.75
- YTD
- +55.04%
- 1 year
- +116.20%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 228.40 +40.7% upside
Now 162.28
- Target (low)
- 205.00
- Target (mean)
- 228.40
- Target (high)
- 267.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
- Strong buy0
- Buy16
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 15
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.73 | -2.31 – -1.05 | -1.03 | -68.1% | 0 | 0.0% | 13 |
| Next quarter | -2.04 | -2.73 – -1.21 | -1.08 | -89.1% | 0 | 0.0% | 13 |
| Current year | -6.39 | -7.84 – -3.95 | -3.71 | -72.2% | 0 | 0.0% | 13 |
| Next year | -7.91 | -13.52 – -1.54 | -6.39 | -23.8% | 24.63M | 0.0% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 21, 2026 | Chardan Capital | Maintained | Buy | Buy |
| May 21, 2026 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 21, 2026 | Chardan Capital | Maintained | Buy | Buy |
| May 12, 2026 | Stephens & Co. | Initiated | — | Overweight |
| Mar 31, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 24, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 16, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Feb 25, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Feb 25, 2026 | BTIG | Maintained | Buy | Buy |
| Feb 24, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Feb 24, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 29, 2026 | BTIG | Reiterated | Buy | Buy |
| Jan 16, 2026 | BTIG | Reiterated | Buy | Buy |
| Jan 7, 2026 | Mizuho | Initiated | — | Outperform |
| Dec 16, 2025 | Truist Securities | Maintained | Buy | Buy |
| Dec 16, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 16, 2025 | TD Cowen | Maintained | Buy | Buy |
| Dec 16, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Dec 15, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 15, 2025 | BTIG | Maintained | Buy | Buy |
| Dec 5, 2025 | Clear Street | Initiated | — | Buy |
| Dec 5, 2025 | BTIG | Initiated | — | Buy |
| Dec 4, 2025 | Craig-Hallum | Initiated | — | Buy |
| Nov 24, 2025 | Stifel | Maintained | Buy | Buy |
| Nov 19, 2025 | Raymond James | Upgrade | Outperform | Strong Buy |
| Nov 13, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 13, 2025 | Chardan Capital | Maintained | Buy | Buy |